# Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension

> **NCT02023450** · EARLY_PHASE1 · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 20 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** saquinavir and ritonavir
- **DRUG:** saquinavir and ritonavir

## Key facts

- **NCT ID:** NCT02023450
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023450, "Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02023450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*